Werewolf Therapeutics, Inc. (HOWL)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $45k
- Jul 7 · Routine
- Form 4 sales
- 57
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleRoutineJun 3 2026
Sold 139,803 shares at $0.46 ($64k)
Evnin Luke, Director
10b5-1 planSold 22.5% of holdings ($283k position)482,776 shares left1.1x usual sizeFiling
- 2 Form 4 saleRoutineJun 8 +5 days
Sold 105,565 shares at $0.41 ($43k)
Evnin Luke, Director
10b5-1 planSold 21.9% of holdings ($197k position)377,211 shares left0.8x usual sizeFiling
- 3 Form 4 saleRoutineJun 9 +1 day
Sold 76,928 shares at $0.37 ($28k)
Evnin Luke, Director
10b5-1 planSold 20.4% of holdings ($140k position)300,283 shares left0.6x usual sizeFiling
- 4 Form 4 saleUnusualJun 11 +2 days
Sold 678,226 shares at $0.37 ($254k)
Kolchinsky Peter, 10% owner
No 10b5-1 planSold 65.2% of holdings ($389k position)361,229 shares leftFirst sale on recordFiling
- 5 Form 4 saleUnusualJun 16 +5 days
Sold 448,836 shares at $0.39 ($174k)
Ra Capital Management, L.P., 10% owner
No 10b5-1 planSold 57.5% of holdings ($302k position)331,414 shares leftFiling
- 6 Form 4 saleUnusualJun 17 +1 day
Sold 416,911 shares at $0.35 ($146k)
Ra Capital Management, L.P., 10% owner
No 10b5-1 planSold 57.9% of holdings ($252k position)303,719 shares leftFiling
- 7 Form 4 saleRoutineJun 29 +12 days
Sold 157,084 shares at $0.30 ($47k)
Evnin Luke, Director
10b5-1 planSold 52.3% of holdings ($90k position)143,199 shares left1.3x usual sizeFiling
- 8 Form 4 saleRoutineJul 7 +8 days
Sold 143,199 shares at $0.31 ($45k)
Evnin Luke, Director
10b5-1 planSold 100% of holdings ($45k position)0 shares left1.1x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (57)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Evnin Luke | Director | Form 4 sale | 143,199 | $45k | 100.0% | Routine | SEC |
| Jun 29, 2026 | Evnin Luke | Director | Form 4 sale | 157,084 | $47k | 52.3% | Routine | SEC |
| Jun 17, 2026 | Ra Capital Management, L.P. | 10% owner | Form 4 sale | 416,911 | $146k | 57.9% | Unusual | SEC |
| Jun 16, 2026 | Ra Capital Management, L.P. | 10% owner | Form 4 sale | 448,836 | $174k | 57.5% | Unusual | SEC |
| Jun 11, 2026 | Kolchinsky Peter | 10% owner | Form 4 sale | 678,226 | $254k | 65.2% | Unusual | SEC |
| Jun 9, 2026 | Evnin Luke | Director | Form 4 sale | 76,928 | $28k | 20.4% | Routine | SEC |
| Jun 8, 2026 | Evnin Luke | Director | Form 4 sale | 105,565 | $43k | 21.9% | Routine | SEC |
| Jun 3, 2026 | Evnin Luke | Director | Form 4 sale | 139,803 | $64k | 22.5% | Routine | SEC |
| May 29, 2026 | Evnin Luke | Director | Form 4 sale | 141,106 | $66k | 18.5% | Routine | SEC |
| May 26, 2026 | Evnin Luke | Director | Form 4 sale | 191,762 | $87k | 20.1% | Routine | SEC |
| May 20, 2026 | Evnin Luke | Director | Form 4 sale | 171,049 | $76k | 15.2% | Routine | SEC |
| May 13, 2026 | Evnin Luke | Director | Form 4 sale | 44,679 | $24k | 3.8% | Routine | SEC |
| May 12, 2026 | Ra Capital Management, L.P. | 10% owner | Form 4 sale | 565,167 | $391k | 58.2% | Unusual | SEC |
| May 12, 2026 | Evnin Luke | Director | Form 4 sale | 407,574 | $280k | 25.8% | Unusual | SEC |
| May 7, 2026 | Evnin Luke | Director | Form 4 sale | 100,581 | $64k | 6.0% | Routine | SEC |
| May 4, 2026 | Evnin Luke | Director | Form 4 sale | 274,619 | $198k | 14.1% | Routine | SEC |
| Apr 29, 2026 | Evnin Luke | Director | Form 4 sale | 205,911 | $155k | 9.5% | Routine | SEC |
| Jan 16, 2026 | Evnin Luke | Director | Form 4 sale | 38,782 | $21k | 1.8% | Routine | SEC |
| Jan 15, 2026 | Evnin Luke | Director | Form 4 sale | 111,227 | $62k | 4.8% | Routine | SEC |
| Jan 12, 2026 | Evnin Luke | Director | Form 4 sale | 91,374 | $54k | 3.8% | Routine | SEC |
| Jan 7, 2026 | Evnin Luke | Director | Form 4 sale | 71,054 | $46k | 2.9% | Routine | SEC |
| Jan 2, 2026 | Evnin Luke | Director | Form 4 sale | 78,377 | $48k | 3.1% | Routine | SEC |
| Dec 29, 2025 | Evnin Luke | Director | Form 4 sale | 291,283 | $185k | 10.2% | Routine | SEC |
| Dec 17, 2025 | Evnin Luke | Director | Form 4 sale | 48,171 | $52k | 1.7% | Routine | SEC |
| Dec 12, 2025 | Evnin Luke | Director | Form 4 sale | 82,971 | $89k | 2.8% | Routine | SEC |
| Dec 9, 2025 | Evnin Luke | Director | Form 4 sale | 95,179 | $95k | 3.1% | Routine | SEC |
| Dec 4, 2025 | MPM BioVentures 2014 (B), L.P. | Other | Form 4 sale | 199,732 | $183k | 4.0% | Routine | SEC |
| Dec 4, 2025 | MPM BioImpact LLC | Other | Form 4 sale | 199,732 | $183k | 4.0% | Routine | SEC |
| Dec 4, 2025 | Evnin Luke | Director | Form 4 sale | 128,185 | $118k | 4.0% | Routine | SEC |
| Dec 1, 2025 | MPM Asset Management Investors BV2014 LLC | 10% owner | Form 4 sale | 141,927 | $137k | 2.8% | Routine | SEC |
| Dec 1, 2025 | UBS Oncology Impact Fund L.P. | 10% owner | Form 4 sale | 141,927 | $137k | 2.8% | Routine | SEC |
| Dec 1, 2025 | Evnin Luke | Director | Form 4 sale | 91,088 | $88k | 2.8% | Routine | SEC |
| Nov 25, 2025 | MPM BioVentures 2014 GP LLC | 10% owner | Form 4 sale | 195,666 | $180k | 3.7% | Routine | SEC |
| Nov 25, 2025 | MPM Oncology Innovations Fund GP LLC | 10% owner | Form 4 sale | 195,666 | $180k | 3.7% | Routine | SEC |
| Nov 25, 2025 | Evnin Luke | Director | Form 4 sale | 125,576 | $115k | 3.7% | Routine | SEC |
| Nov 20, 2025 | MPM BioVentures 2014 LLC | 10% owner | Form 4 sale | 160,103 | $148k | 2.9% | Routine | SEC |
| Nov 20, 2025 | MPM Oncology Innovations Fund GP LLC | 10% owner | Form 4 sale | 160,103 | $148k | 2.9% | Routine | SEC |
| Nov 20, 2025 | Evnin Luke | Director | Form 4 sale | 102,753 | $95k | 2.9% | Routine | SEC |
| Nov 17, 2025 | MPM BioVentures 2014 LLC | 10% owner | Form 4 sale | 209,652 | $201k | 3.7% | Routine | SEC |
| Nov 17, 2025 | MPM Oncology Innovations Fund GP LLC | 10% owner | Form 4 sale | 209,652 | $201k | 3.7% | Routine | SEC |
| Nov 17, 2025 | Evnin Luke | Director | Form 4 sale | 134,553 | $129k | 3.7% | Routine | SEC |
| Nov 12, 2025 | MPM BioVentures 2014, L.P. | 10% owner | Form 4 sale | 213,529 | $241k | 3.6% | Routine | SEC |
| Nov 12, 2025 | UBS Oncology Impact Fund L.P. | 10% owner | Form 4 sale | 213,529 | $241k | 3.6% | Routine | SEC |
| Nov 12, 2025 | Evnin Luke | Director | Form 4 sale | 137,041 | $155k | 3.6% | Routine | SEC |
| Nov 6, 2025 | MPM BioVentures 2014 LLC | 10% owner | Form 4 sale | 242,890 | $296k | 4.0% | Routine | SEC |
| Nov 6, 2025 | MPM BioImpact LLC | 10% owner | Form 4 sale | 242,890 | $296k | 4.0% | Routine | SEC |
| Nov 6, 2025 | Evnin Luke | Director | Form 4 sale | 155,885 | $190k | 4.0% | Routine | SEC |
| Nov 3, 2025 | MPM Asset Management Investors BV2014 LLC | 10% owner | Form 4 sale | 295,043 | $392k | 4.6% | Routine | SEC |
| Nov 3, 2025 | Mpm Oncology Innovations Fund LP | 10% owner | Form 4 sale | 295,043 | $392k | 4.6% | Routine | SEC |
| Nov 3, 2025 | Evnin Luke | Director | Form 4 sale | 189,356 | $251k | 4.6% | Routine | SEC |
| Oct 29, 2025 | Evnin Luke | Director | Form 4 sale | 177,145 | $286k | 4.1% | Routine | SEC |
| Oct 29, 2025 | MPM BioVentures 2014 LLC | 10% owner | Form 4 sale | 276,017 | $446k | 4.1% | Routine | SEC |
| Oct 29, 2025 | UBS Oncology Impact Fund L.P. | 10% owner | Form 4 sale | 276,017 | $446k | 4.1% | Routine | SEC |
| Mar 27, 2025 | MPM Asset Management Investors BV2014 LLC | 10% owner | Form 4 sale | 1,963 | $2k | 0.1% | No plan | SEC |
| Mar 27, 2025 | Evnin Luke | Director, 10% owner | Form 4 sale | 2,425 | $3k | 0.1% | No plan | SEC |
| Mar 27, 2025 | Mpm Asset Management LLC | 10% owner | Form 4 sale | 4,386 | $5k | 0.1% | No plan | SEC |
| Dec 15, 2021 | Leonard Reid | Chief Operating Officer | Form 4 sale | 3,000 | $40k | 2.4% | Plan not stated | SEC |